Amoéba attracts the German market

Lyon, Cleveland, June 27th, 2017 - AMOEBA announced today the development of a collaboration with VISCUS BIOLOGICS in order to carry out collective testing on a new wound care application in the field of human health.

VISCUS BIOLOGICS has a proven expertise in the field of wound care products, in particular collagen-based dressings. Following preliminary in vitro testing, the two companies intend to extend their cooperation and further confirm, through additional in vitro and in vivo testing, the action of the Willaertia magna C2c Maky micro-organism against certain pathogenic Multi-Drug Resistant (MDR) bacteria that resist multiple antibiotics.  Willaertia magna C2c Maky could therefore be used with advanced wound care dressings. This project is in the first instance focusing on the US market.

Lyon, France & Chicago, USA, May 22nd, 2017 – Amoéba announced today the signature with Earthwise Environmental of the first Distribution Agreement in the USA for its BIOMEBA product. This agreement covers the territory of Texas, Oklahoma, Illinois, Indiana, and Wisconsin. 

Lyon, Houten, May 15^th 2017 – Amoéba announced today that it has signed a distribution agreement for its BIOMEBA product with NOVOCHEM Water Treatment. The collaboration between NOVOCHEM and AMOEBA started in 2015 with the signature of a Letter of Intention (LOI) for the distribution of BIOMEBA in Benelux.

Lyon, Craiova, May 4^th 2017 – Amoéba announced today that it has signed a Letter of Intent (LOI) with BLUE NEON SRL prior to entering into a definitive agreement regarding the distribution of its product in Romania.

Lyon (France), Pittsburg (PA, USA), February 2^nd, 2017 - Amoéba announced today that it has signed a Letter of Intent (LOI) with KROFF Chemical Company (KROFF) prior to entering into a definitive agreement regarding the distribution of its product in the United States.

Lyon (France), Burlingame (CA, USA), January 11^th, 2017 - Amoéba announced today that it has signed a Letter of Intent (LOI) with GARRATT-CALLAHAN prior to entering into a definitive agreement regarding the distribution of its product in the Unites States.

Lyon, Castello d’Argile, 5th January 2017 -  Amoéba announced today that it has signed a Letter of Intent (LOI) with NCR Biochemical prior to entering into a definitive agreement regarding the distribution of its BIOMEBA product in Italy.

Lyon, Bergondo, 15th December 2016 – Amoéba announced today that it has signed a Letter of Intent (LOI) with OXIDINE prior to entering into a definitive agreement regarding the distribution of its BIOMEBA product in Spain.

On November 29, 2016, during Pollutec, Mr Christohe Sirugue (State Secretary in charge of industry at the French Ministry for Economy and Finances) visited Amoéba’s production site.